Skip to content
★ Sign in to follow
GA
Total declarations
13
Company
1
▲ Purchases (2 ops.)
€27k
▼ Sales (0 ops.)
—

Latest filing published 11 Jan 2019 for CorMedix Inc..

Filing timeline

BuySale
Gary A. Gelbfish

Insider track record

Disclosed buys
2
Disclosed sells
0
Signal history

Closed purchases

Market purchases
2
Positive at T+90
50%
Median T+90
+8.0%

Based on 2 purchases whose 90-day window has closed (published at least 91 days ago), the same population our ranking model reads.

Purchases by company

Since each purchase

  • Filed 14 Dec 2017 · 3252 days ago · €21k
    +122.8%
    Entry US$2.85 · Close at T+365 US$6.35
  • Filed 20 Dec 2011 · 5438 days ago · €5,924
    +100.0%
    Entry US$1.50 · Close at T+365 US$3.00

Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.

Gary A. Gelbfish: trading record in brief

All filings by Gary A. Gelbfish on record concern CorMedix Inc. We count 13 filings; the first trade dates from 30 March 2010 and the latest from 10 January 2019.

On the market, this insider has only ever bought: 2 purchases, €27k in total. Buying on the open market means paying the going price with one's own funds, a different act from receiving shares as pay. Besides market trades, the filings include 6 share grants and 2 option exercises.

The newest entry dates from 11 January 2019: a share grant, in CorMedix Inc. The clock since the last published purchase (14 December 2017) now reads 3,252 days. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 4 days. The legal deadline for a Form 4 is two business days after the transaction. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.

Companies and markets linked to Gary A. Gelbfish

Open company profiles for insider transactions, fundamentals and analyst consensus when available.

Declarations10 total
  • ◆
    DirectorExecutivesCorMedix Inc.
    0SEC
    12,500 sharesRestricted Stock UnitsSEC:0001654954-19-000380:0
  • ◆
    DirectorExecutivesCorMedix Inc.
    0SEC
    10,000 sharesCommon StockSEC:0001654954-18-013415:0
  • ◇
    DirectorExecutivesCorMedix Inc.
    1M USD19SEC
    1,000,000 shares@ US$1.05100.0% of flowCommon StockSEC:0001654954-18-011239:0
  • ▲
    DirectorExecutivesCorMedix Inc.
    25,000 USD29SEC
    52,083 shares@ US$0.482.3% of flowCommon Stock, $0.001 par value per shareSEC:0001654954-17-011653:0
    Canonical exit: 12 Mar 2018 (T+90)
  • ◆
    DirectorExecutivesCorMedix Inc.
    100,000 USD0SEC
    250,000 shares@ US$0.40Common Stock, $0.001 par value per shareSEC:0001144204-14-003346:0
  • ◆
    DirectorExecutivesCorMedix Inc.
    100,000 USD0SEC
    36,455 shares@ US$2.7431Common Stock, $0.001 par value per shareSEC:0001144204-14-003346:1
  • ●
    DirectorExecutivesCorMedix Inc.
    100,000 USD0SEC
    285,714 shares@ US$0.35Common Stock, $0.001 par value per shareSEC:0001144204-13-051986:0
  • ▲
    DirectorExecutivesCorMedix Inc.
    7,719 USD0SEC
    23,300 shares@ US$0.3313Common Stock, $0.001 par value per shareSEC:0001144204-11-070838:0
    Canonical exit: 15 Mar 2012 (T+90)
  • ●
    DirectorExecutivesCorMedix Inc.
    0SEC
    165,368 sharesCommon Stock, $0.001 par value per shareSEC:0001193805-10-000960:0
  • ●
    DirectorExecutivesCorMedix Inc.
    0SEC
    70,872 sharesCommon Stock, $0.001 par value per shareSEC:0001193805-10-000960:1

10 of 10 declarations